FDA rejects Incyte cancer drug, asking for more data to show clinical benefit July 26, 2021 Auto Bot BioPharma, biopharma nl, cancer, Clinical Trials, FDA, Incyte, Legal, Pharma 0 An Incyte drug developed as a treatment for a rare type of anal cancer has fallen short of FDA approval. The regulator said it needs to see more clinical data that demonstrating clinical benefit for the antibody drug.